In the present study, the MSI frequency of tumor-related genes, except BBC3 and MYC, was higher in B5-MSI tumors than in B5-MSS tumors, suggesting that the B5 panel is a powerful tool for defining the MSI status of CRC. The gene discussed is MYC; the disease is neoplasm.